The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BTG to buy Novate for up to $130m

Fri, 07th Sep 2018 07:04

(Sharecast News) - Healthcare company BTG on Friday said it was paying up to $130m in cash to buy Ireland-based Novate, which specialises in the prevention of pulmonary embolism (PE) in patients at high risk of venous thromboembolic events.BTG will pay $20m in cash up front with more forthcoming "if certain commercial and sales-related milestones are met". The transaction is expected to be accretive to adjusted EPS from the second full year of ownership, BTG said.Novate has developed Sentry, the first bioconvertible inferior vena cava which has recently been granted 510(k) regulatory clearance in the US.Sentry's 12 month clinical trial data demonstrated no new symptomatic PE and no evidence of device migration, tilt, fracture, perforation or embolization, complications which have been associated with some other IVC filters, BTG said.The unique bioconversion feature eliminates the need for an additional interventional procedure to retrieve the device.BTG plans to launch Sentry in the US in the second half of the 2018/19 financial year and will sell the device through its existing vascular sales force."This bolt-on acquisition further enhances BTG's strength in the vascular space." said BTG chief executive Louise Makin."Novate's unique IVC filter offers our existing customers a highly complementary product in the management of PE."
More News
17 Oct 2016 10:15

Monday broker round-up

(ShareCast News) - Coca Cola Hellenic: Jefferies keeps at buy with a target price of 2100p. Jupiter Fund Management: Societe Generale downgrades to hold, 490p target. Aveva: Barclays keeps at equal-weight with a 1450p target. Arrow Global: Numis upgrades to buy with a 405p target. Close Brothers

Read more
6 Oct 2016 15:00

FTSE 250 movers: Gold miner Hochschild leads mid-caps lower

(ShareCast News) - The FTSE 250 retreated further away from its all-time high on Thursday, stung by Brexit worries and investor caution that it may be vulnerable to the reaction to Friday's US non-farm payrolls report. After business group's stressed the importance of immigration to government earli

Read more
6 Oct 2016 13:45

BTG lifts revenue guidance on weak sterling

(ShareCast News) - FTSE 250 specialist healthcare group BTG lifted its revenue guidance for the year on the back of the weak pound. In an update for the six months to 30 September, the company said it now expects reported full-year revenue to be ahead of its previously-announced range of £510m to £5

Read more
15 Jul 2016 15:00

Friday broker round-up

(ShareCast News) - Ashmore: Goldman Sachs upgrades to buy with a target price of 420p and JP Morgan reiterates underweight with a 250p target. G4S: UBS keeps at buy with a 240p target. Essentra: Jefferies reiterates buy with a 715p target. Playtech: UBS stays at buy with a 1000p target. Aberdeen:

Read more
14 Jul 2016 16:06

LONDON MARKET CLOSE: Stocks Mixed But Pound Higher After BoE Stays Put

Read more
14 Jul 2016 11:23

LONDON MARKET MIDDAY: Stocks Drop As Bank Of England Waits For August

Read more
14 Jul 2016 09:42

WINNERS & LOSERS SUMMARY: SuperGroup Shares Soar On Special Dividend

Read more
14 Jul 2016 09:07

BTG loses out on sterling benefit due to hedging and dollar costs

(ShareCast News) - Healthcare company BTG said it would make little gains from the collapse of the pound as its currency hedging contracts would negate the potential revenue benefits from the stronger dollar. The FTSE 250 company, in a statement issued ahead of its annual shareholder meeting and aft

Read more
14 Jul 2016 07:28

LONDON MARKET OPEN: Hays Leads FTSE 250 Gainers Ahead Of BoE Decision

Read more
14 Jul 2016 07:00

BTG Trades In Line With Expectations, Benefits From Weak Sterling

Read more
12 Jul 2016 08:32

BROKER RATINGS SUMMARY: Vodafone Cut To Neutral, ITV Raised To Neutral

Read more
7 Jul 2016 15:16

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jul 2016 15:13

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Jul 2016 10:17

BTG Says US Regulator Approves Shelf Life Extension For Varithena

Read more
29 Jun 2016 08:48

BROKER RATINGS SUMMARY: Merrill Lynch Upgrades Burberry To Buy

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.